WTA to mandate genetic sex tests

The Women's Tennis Association (WTA) announced it will require all players to undergo genetic sex testing, using a cheek swab or saliva sample to detect the SRY gene, as part of its new eligibility policy starting in 2026. Players will be tested once; a positive result will lead to further medical evaluation before competing. The policy aims to ensure fair competition and aligns with similar regulations introduced by World Athletics and World Boxing.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل